These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19264852)

  • 21. Understanding biomarkers of neurodegeneration: Ultrasensitive detection techniques pave the way for mechanistic understanding.
    Blennow K; Zetterberg H
    Nat Med; 2015 Mar; 21(3):217-9. PubMed ID: 25742456
    [No Abstract]   [Full Text] [Related]  

  • 22. Treat Alzheimer disease before it is symptomatic.
    Rosenberg RN
    Arch Neurol; 2011 Oct; 68(10):1237-8. PubMed ID: 21670383
    [No Abstract]   [Full Text] [Related]  

  • 23. Biomarkers for Alzheimer's disease. The research advances incrementally, but clinical use is still years away.
    Harv Ment Health Lett; 2010 Nov; 27(5):1-3. PubMed ID: 21218612
    [No Abstract]   [Full Text] [Related]  

  • 24. Alzheimer disease: Cerebrospinal fluid markers for AD change during middle age.
    Chase A
    Nat Rev Neurol; 2015 Aug; 11(8):427. PubMed ID: 26215625
    [No Abstract]   [Full Text] [Related]  

  • 25. The application of cerebrospinal fluid biomarkers in early diagnosis of Alzheimer disease.
    Blennow K; Zetterberg H
    Med Clin North Am; 2013 May; 97(3):369-76. PubMed ID: 23642576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Are CSF biomarkers ready for prime time as diagnostics for Alzheimer disease? Interview by Rebecca Voelker.
    Holtzman DM
    JAMA; 2010 Nov; 304(17):1887. PubMed ID: 21045090
    [No Abstract]   [Full Text] [Related]  

  • 27. Changes of neurocalcin, a calcium-binding protein, in the brain of patients with Alzheimer's disease.
    Shimohama S; Chachin M; Taniguchi T; Hidaka H; Kimura J
    Brain Res; 1996 Apr; 716(1-2):233-6. PubMed ID: 8738246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum and cerebrospinal fluid levels of visinin-like protein-1 in acute encephalopathy with biphasic seizures and late reduced diffusion.
    Hasegawa S; Matsushige T; Inoue H; Takahara M; Kajimoto M; Momonaka H; Oka M; Isumi H; Emi S; Hayashi M; Ichiyama T
    Brain Dev; 2014 Aug; 36(7):608-12. PubMed ID: 24075506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cerebrospinal fluid opens a window on Alzheimer disease.
    Galasko D
    Arch Neurol; 1999 Jun; 56(6):655-6. PubMed ID: 10369301
    [No Abstract]   [Full Text] [Related]  

  • 30. Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients.
    Braunewell K; Riederer P; Spilker C; Gundelfinger ED; Bogerts B; Bernstein HG
    Dement Geriatr Cogn Disord; 2001; 12(2):110-6. PubMed ID: 11173883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New biochemical markers in Alzheimer disease.
    Diaz-Arrastia R; Baskin F
    Arch Neurol; 2001 Mar; 58(3):354-6. PubMed ID: 11255437
    [No Abstract]   [Full Text] [Related]  

  • 32. Self-reported sleep and Alzheimer disease CSF biomarkers: A wake-up call.
    Spira AP; Ju YS
    Neurology; 2017 Aug; 89(5):419-420. PubMed ID: 28679599
    [No Abstract]   [Full Text] [Related]  

  • 33. Full sequence of neurocalcin, a novel calcium-binding protein abundant in central nervous system.
    Okazaki K; Watanabe M; Ando Y; Hagiwara M; Terasawa M; Hidaka H
    Biochem Biophys Res Commun; 1992 May; 185(1):147-53. PubMed ID: 1599450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neurocalcin, a novel calcium binding protein with three EF-hand domains, expressed in retinal amacrine cells and ganglion cells.
    Nakano A; Terasawa M; Watanabe M; Usuda N; Morita T; Hidaka H
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1207-11. PubMed ID: 1510655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuronal calcium sensor proteins are direct targets of the insulinotropic agent repaglinide.
    Okada M; Takezawa D; Tachibanaki S; Kawamura S; Tokumitsu H; Kobayashi R
    Biochem J; 2003 Oct; 375(Pt 1):87-97. PubMed ID: 12844348
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiplex method for measuring biomarkers of Alzheimer disease in cerebrospinal fluid.
    Miller BB; Mandell JW
    Clin Chem; 2005 Feb; 51(2):289-90. PubMed ID: 15681556
    [No Abstract]   [Full Text] [Related]  

  • 37. Visinin-Like Protein-3 Modulates the Interaction Between Cytochrome b
    Oikawa K; Odero GL; Nafez S; Ge N; Zhang D; Kobayashi H; Sate K; Kimura S; Tateno M; Albensi BC
    Cell Biochem Biophys; 2016 Dec; 74(4):449-457. PubMed ID: 27372904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers for Alzheimer disease in cerebrospinal fluid, urine, and blood.
    Lönneborg A
    Mol Diagn Ther; 2008; 12(5):307-20. PubMed ID: 18803429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Double Monoclonal Immunoassay for Quantifying Human Visinin-Like Protein-1 in CSF.
    Crimmins DL; Herries EM; Ohlendorf MF; Brada NA; Garbett NC; Zipfel GJ; Schindler SE; Ladenson JH
    Clin Chem; 2017 Feb; 63(2):603-604. PubMed ID: 27986783
    [No Abstract]   [Full Text] [Related]  

  • 40. Biomarkers for the early diagnosis of Alzheimer's disease.
    de Leon MJ; Klunk W
    Lancet Neurol; 2006 Mar; 5(3):198-9. PubMed ID: 16488371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.